Terms: = Leukemia AND LDH AND Treatment
396 results:
1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. [Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic leukemia/Lymphoma from Multicenter].
Li ZH; Luo L; Yang P; Li Y; Zou DH; Gao CJ; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):120-124. PubMed ID: 38387909
[TBL] [Abstract] [Full Text] [Related]
3. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
[TBL] [Abstract] [Full Text] [Related]
4. [Efficacy and safety of first-line treatment with anti-CD38 monoclonal antibody-based regimen for primary plasma cell leukemia].
Dou XL; Liu RX; Liu Y; Peng N; Wen L; Wu Y; Li Q; Zhong YP; Zhou X; Liao AJ; Jiang HN; Ma XJ; Dong HH; Fan SJ; Zhao YQ; Hu DH; Lu J
Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):499-506. PubMed ID: 38317361
[No Abstract] [Full Text] [Related]
5. "Combination treatments of imatinib with astaxanthin and crocin efficiently ameliorate antioxidant status, inflammation and cell death progression in imatinib-resistant chronic myeloid leukemia cells".
Golestani A; Rahimi A; Najafzadeh M; Sayadi M; Sajjadi SM
Mol Biol Rep; 2024 Jan; 51(1):108. PubMed ID: 38227060
[TBL] [Abstract] [Full Text] [Related]
6. Artificial intelligence-based prediction models for acute myeloid leukemia using real-life data: A DATAML registry study.
Didi I; Alliot JM; Dumas PY; Vergez F; Tavitian S; Largeaud L; Bidet A; Rieu JB; Luquet I; Lechevalier N; Delabesse E; Sarry A; De Grande AC; Bérard E; Pigneux A; Récher C; Simoncini D; Bertoli S
Leuk Res; 2024 Jan; 136():107437. PubMed ID: 38215555
[TBL] [Abstract] [Full Text] [Related]
7. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
[TBL] [Abstract] [Full Text] [Related]
8. [Metformin mitigates doxorubicin-induced cardiotoxicity
Wei J; Yang Q; Lin L; Zhu C; Wei J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1682-1688. PubMed ID: 37933643
[TBL] [Abstract] [Full Text] [Related]
9. Richter transformation - retrospective treatment outcomes analysis in Polish Adult leukemia Study Group.
Sośnia O; Pruszczyk K; Danecki M; Wąsik-Szczepanek E; Tryc-Szponder J; Iskierka-Jażdżewska E; Majeranowski A; Krzemień H; Bołkun Ł; Paszkiewicz-Kozik E; Drozd-Sokołowska J; Kwiatkowski J; Wiśniewska-Organek D; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Budziszewska B; Jamroziak K; Hus I; Lech-Marańda E; Puła B
Leuk Lymphoma; 2024 Feb; 65(2):175-186. PubMed ID: 37921067
[TBL] [Abstract] [Full Text] [Related]
10. Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study.
Fattizzo B; Gurnari C; Cassanello G; Bortolotti M; Awada H; Giammarco S; Consonni D; Sica S; Gandhi S; Trikha R; Large J; Salter S; Maciejewski JP; Barcellini W; Kulasekararaj AG
Leukemia; 2023 Dec; 37(12):2479-2485. PubMed ID: 37794100
[TBL] [Abstract] [Full Text] [Related]
11. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic leukemia Patients.
Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic leukemia.
Aref S; El Tantawy A; Gouda E; Ayed M
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
[TBL] [Abstract] [Full Text] [Related]
14. Chromosomal aberrations and prognostic analysis of secondary acute myeloid leukemia-a retrospective study.
Song M; Zhang T; Yang D; Xiao H; Wang H; Ye Q; Zhai Z
PeerJ; 2023; 11():e15333. PubMed ID: 37214104
[TBL] [Abstract] [Full Text] [Related]
15. [Adult T-cell leukemia/lymphoma with multiple intracranial masses and CMV and HHV-6 reactivation at initial presentation].
Hori T; Yasui S; Hosoki M; Yamagami H; Otoda T; Yuasa T; Aihara KI; Takishita M; Abe M; Nakamura S
Rinsho Ketsueki; 2023; 64(4):283-289. PubMed ID: 37121773
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical Characteristics and Survival Analysis of Patients with Chronic Myelomonocytic leukemia].
Wang JY; Chen JF; Wang SF; Guo QH; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):476-482. PubMed ID: 37096522
[TBL] [Abstract] [Full Text] [Related]
17. [treatment responses, outcomes, and prognostic factors associated with them in patients with secondary acute myeloid leukemia].
Ma L; Zhao T; Chen YY; Jiang H; Xu LP; Zhang XH; Wang Y; Sun YQ; Mo XD; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):124-131. PubMed ID: 36948866
[No Abstract] [Full Text] [Related]
18. Clinical outcomes and characteristics of patients with
Zhang L; Chen K; Li Y; Chen Q; Shi W; Ji T; Tao H; He Z; Wang C; Yu L
Hematology; 2023 Dec; 28(1):2181773. PubMed ID: 36892252
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive analysis of clinicalf eatures, treatment options, overall survival, and prognostic factors in lymphoma cell leukemia patients: A retrospective study.
Kang Y; Fang K; Wang M
J Cancer Res Ther; 2022 Dec; 18(7):1961-1966. PubMed ID: 36647956
[TBL] [Abstract] [Full Text] [Related]
20. Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research.
Schoettler ML; Carreras E; Cho B; Dandoy CE; Ho VT; Jodele S; Moissev I; Sanchez-Ortega I; Srivastava A; Atsuta Y; Carpenter P; Koreth J; Kroger N; Ljungman P; Page K; Popat U; Shaw BE; Sureda A; Soiffer R; Vasu S
Transplant Cell Ther; 2023 Mar; 29(3):151-163. PubMed ID: 36442770
[TBL] [Abstract] [Full Text] [Related]
[Next]
